Learn more about our product portfolios:
Our broad portfolio is the foundation from which we make healthy possible. In the US, our portfolio of more than 270 medicines provides patients with more affordable access to quality medicines. Our growing Specialty portfolio meets important medical needs in central nervous system disorders, endocrinology and other therapeutic categories. We are also excited about our work to bring patients more affordable biologic therapy options through our Biosciences, which includes a broad portfolio of institutional injectables as well as Amneal’s growing biosimilars portfolio. And we’re working to expand our business across select international markets.